Announcements Trials
Browse Landscape

Status

Completed 97Active not recruiting 9Unknown 6Terminated 6Recruiting 5Withdrawn 4Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 56INDUSTRY 6OTHER_GOV 1NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Sarcoma, Kaposi 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Lymphoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Neoplasms 1Musculoskeletal Pain 1Multiple Myeloma 1Malignant Solid Neoplasm 1Lymphoma, Non-Hodgkin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT06721598 2024-12-06

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

National Research Center for Hematology, Russia

Not yet recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡